Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Halle (Saale) – page 38

1 023 clinical trials in Halle (Saale), Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Halle (Saale) at a glance
1 023
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 023 trials in Halle (Saale)

Open in trial search

Systemic scleroderma+1

Not yet recruiting

Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:CC-97540
  • Sponsor:Celgene Corp.

Systemic candida

Not yet recruiting

Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Caspofungin Acetate
  • Sponsor:University Of Cologne

Infertility male

Not yet recruiting

Follitropin Alfa and Chorionic Gonadotrophin for Men with Male Infertility, Low Testosterone, and Low Sperm Count

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg

Hereditary haemochromatosis

Not yet recruiting

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Vamifeport trihydrochloride
  • Sponsor:CSL Behring LLC

Acute lymphocytic leukaemia+1

Not yet recruiting

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Amgen Inc.

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC

A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Pharyngitis

Not yet recruiting

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin degludec
  • Sponsor:Novo Nordisk A/S

Systemic lupus erythematosus+1

Not yet recruiting

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:CC-97540
  • Sponsor:Celgene Corp.

Medulloblastoma

Not yet recruiting

Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Halle (Saale)

What the registry says about research in the country

01 Oncology and Hematologic Malignancies

Clinical research in Halle (Saale) is strongly focused on cancer and blood disorders, with studies exploring new treatment options for solid tumors and leukemia, lymphoma, and related conditions.

  • Neoplasms and hematologic malignancies
  • Acute myeloid leukemia, lymphoma, and multiple myeloma
  • Testing newer combinations and more effective treatment strategies
  • Evaluating outcomes in advanced, relapsed, or high-risk disease

Many studies in this area aim to improve survival, disease control, and treatment options for patients with limited standard choices.

02 Lung and Respiratory Diseases

Another major research area covers respiratory tract diseases, especially non-small cell lung cancer, small cell lung cancer, and chronic lung conditions such as COPD and pulmonary fibrosis.

  • Non-small cell lung cancer and small cell lung cancer
  • Chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis
  • Assessing new therapies and maintenance approaches
  • Improving symptom control and long-term respiratory outcomes

The studies often focus on better disease management for both advanced cancers and chronic inflammatory lung disease.

03 Gastroenterology and Inflammatory Bowel Disease

Trials in digestive system diseases and immune-related disorders include important work on Crohn’s disease, ulcerative colitis, and other inflammatory conditions of the gut.

  • Crohn’s disease and ulcerative colitis
  • Coeliac disease and gastrointestinal inflammation
  • Studying new immune-targeted treatments
  • Improving control of active disease and remission rates

These projects aim to reduce symptoms, support remission, and improve quality of life for people with chronic intestinal disease.

04 Cardiovascular and Stroke Research

Cardiovascular diseases are represented by studies on heart failure, atrial fibrillation, stroke, and related complications after surgery or acute vascular events.

  • Heart failure and atrial fibrillation
  • Acute ischemic stroke and vascular occlusion
  • Testing ways to prevent complications and improve recovery
  • Evaluating safer and more effective cardiovascular care

Research in this field is aimed at lowering risk, improving emergency treatment, and supporting long-term heart and brain health.

05 Autoimmune and Immune-Mediated Disorders

Halle’s trial portfolio includes a broad set of studies on immune system diseases, including rheumatologic, skin-related, and other inflammatory conditions.

  • Lupus erythematosus, hidradenitis suppurativa, and giant cell arteritis
  • Atopic dermatitis and chronic spontaneous urticaria
  • Exploring immune-modulating therapies
  • Looking to reduce inflammation and improve daily functioning

These studies reflect a strong interest in better control of chronic immune-driven disease.

06 Hematology, Bone Marrow Transplantation, and Blood Clotting Disorders

A significant share of research addresses myeloid disorders, myeloproliferative neoplasms, and complications linked to stem cell transplantation.

  • Myelodysplastic syndromes, myelofibrosis, and essential thrombocythemia
  • Graft-versus-host disease and transplant-related complications
  • Evaluating better blood cancer and transplant treatments
  • Improving safety and disease control in high-risk patients

Much of this work focuses on patients with difficult-to-treat disease and the need for more precise supportive care.

07 Pediatric Oncology and Rare Childhood Diseases

The city also supports research into children’s cancers and other rare pediatric conditions, including tumors of the brain, blood, and soft tissue.

  • Medulloblastoma, neuroblastoma, and rhabdomyosarcoma
  • Acute lymphoblastic leukemia in children and adolescents
  • Testing more effective and less burdensome treatment approaches
  • Seeking better survival and long-term outcomes for young patients

These trials often aim to refine treatment so that cure rates improve while limiting lasting harm.

08 Neurology and Nervous System Conditions

Research also includes nervous system diseases such as stroke, multiple sclerosis, spinal cord injury, and certain rare neurological disorders.

  • Secondary progressive multiple sclerosis
  • Acute spinal cord injury and idiopathic sudden hearing loss
  • Evaluating therapies that may improve recovery or slow progression
  • Exploring care options for serious and uncommon neurological conditions

These studies are aimed at improving function, symptom relief, and neurological outcomes over time.

09 Metabolic, Kidney, and Endocrine Conditions

Trials in nutritional and metabolic diseases and kidney-related disorders focus on conditions that affect energy balance, organ function, and long-term health.

  • Obesity, metabolic disease, and mitochondrial disease
  • Chronic kidney disease and kidney-related complications
  • Studying ways to slow disease progression
  • Assessing treatments that may improve overall organ health

This area reflects interest in both common chronic illness and rarer inherited disorders.

10 Eye, Ear, and Other Diagnostic Research

Several studies address eye diseases, ear and nose conditions, and broader diagnostic techniques, showing a strong interest in improving how disease is detected and managed.

  • Diabetic macular edema and other vision-threatening eye conditions
  • Hearing loss and otologic disorders
  • Improving diagnosis and monitoring
  • Testing therapies that may preserve vision or sensory function

These projects highlight the role of better diagnostics alongside treatment development in everyday clinical care.

11 Infectious Diseases, Surgery, and Public Health

There is also work on bacterial infections, viral diseases, surgical complications, and public health questions, including prevention and perioperative care.

  • Viral and bacterial infections
  • Surgical bleeding, infection prevention, and post-operative complications
  • Evaluating supportive treatments and preventive strategies
  • Improving safety in hospital and surgical settings

These trials focus on practical clinical needs, from infection control to safer recovery after procedures.

12 Psychiatry and Behavioral Health

Some research in Halle addresses mental disorders and behavioral disciplines, reflecting interest in both emotional health and broader patient well-being.

  • Attention deficit hyperactivity disorder and borderline personality disorder
  • Studying approaches that may improve symptoms and functioning
  • Supporting better understanding of complex behavioral conditions
  • Exploring patient-centered care in mental health

These studies contribute to broader clinical research beyond traditional somatic disease areas.

13 Women’s Health, Fertility, and Urogenital Disorders

Trials also include female and male urogenital diseases, pregnancy-related issues, and fertility-related concerns, showing a balanced interest in reproductive health.

  • Pregnancy complications and vaginal infections
  • Infertility and urogenital disorders
  • Testing therapies for symptom relief and prevention
  • Improving health outcomes for women and men

These studies often aim to make everyday gynecologic and reproductive care more effective.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.